{{Rsnum
|rsid=2980976
|Chromosome=18
|position=62412879
|Orientation=plus
|GMAF=0.1965
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 29.5 | 70.5
| HCB | 5.1 | 36.5 | 58.4
| JPT | 6.2 | 38.1 | 55.8
| YRI | 4.8 | 34.7 | 60.5
| ASW | 3.5 | 28.1 | 68.4
| CHB | 5.1 | 36.5 | 58.4
| CHD | 8.3 | 38.5 | 53.2
| GIH | 16.8 | 49.5 | 33.7
| LWK | 3.6 | 37.3 | 59.1
| MEX | 1.7 | 19.0 | 79.3
| MKK | 7.1 | 28.8 | 64.1
| TSI | 5.9 | 35.3 | 58.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23241943
  |Trait=Response to antipsychotic treatment
  |Title=Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.
  |RiskAllele=A
  |Pval=3E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}